Report Detail

Other Global Prostate Specific Antigen (PSA) Biomarker Market Size, Status and Forecast 2019-2025

  • RnM3841579
  • |
  • 10 June, 2020
  • |
  • Global
  • |
  • 97 Pages
  • |
  • QYResearch
  • |
  • Other

This report focuses on the global Prostate Specific Antigen (PSA) Biomarker status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prostate Specific Antigen (PSA) Biomarker development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Abbott
Siemens Healthcare
DiaSorin
Roche
Tosoh Bioscience
Fujirebio
BodiTech
GE Healthcare
Endocare
Quest Diagnostics
Bio-Rad Laboratories
QIAGEN
Myriad RBM

Market segment by Type, the product can be split into
Blood
Semen
Urine
Market segment by Application, split into
Diagnostics
Drug Discovery
Personalized Medicine
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Prostate Specific Antigen (PSA) Biomarker status, future forecast, growth opportunity, key market and key players.
To present the Prostate Specific Antigen (PSA) Biomarker development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Prostate Specific Antigen (PSA) Biomarker are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Prostate Specific Antigen (PSA) Biomarker Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Prostate Specific Antigen (PSA) Biomarker Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Blood
    • 1.4.3 Semen
    • 1.4.4 Urine
  • 1.5 Market by Application
    • 1.5.1 Global Prostate Specific Antigen (PSA) Biomarker Market Share by Application: 2020 VS 2026
    • 1.5.2 Diagnostics
    • 1.5.3 Drug Discovery
    • 1.5.4 Personalized Medicine
    • 1.5.5 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Prostate Specific Antigen (PSA) Biomarker Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Prostate Specific Antigen (PSA) Biomarker Industry
      • 1.6.1.1 Prostate Specific Antigen (PSA) Biomarker Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Prostate Specific Antigen (PSA) Biomarker Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Prostate Specific Antigen (PSA) Biomarker Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Prostate Specific Antigen (PSA) Biomarker Market Perspective (2015-2026)
  • 2.2 Prostate Specific Antigen (PSA) Biomarker Growth Trends by Regions
    • 2.2.1 Prostate Specific Antigen (PSA) Biomarker Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Prostate Specific Antigen (PSA) Biomarker Historic Market Share by Regions (2015-2020)
    • 2.2.3 Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Prostate Specific Antigen (PSA) Biomarker Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Prostate Specific Antigen (PSA) Biomarker Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Prostate Specific Antigen (PSA) Biomarker Players by Market Size
    • 3.1.1 Global Top Prostate Specific Antigen (PSA) Biomarker Players by Revenue (2015-2020)
    • 3.1.2 Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Prostate Specific Antigen (PSA) Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Prostate Specific Antigen (PSA) Biomarker Market Concentration Ratio
    • 3.2.1 Global Prostate Specific Antigen (PSA) Biomarker Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Prostate Specific Antigen (PSA) Biomarker Revenue in 2019
  • 3.3 Prostate Specific Antigen (PSA) Biomarker Key Players Head office and Area Served
  • 3.4 Key Players Prostate Specific Antigen (PSA) Biomarker Product Solution and Service
  • 3.5 Date of Enter into Prostate Specific Antigen (PSA) Biomarker Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Prostate Specific Antigen (PSA) Biomarker Historic Market Size by Type (2015-2020)
  • 4.2 Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Type (2021-2026)

5 Prostate Specific Antigen (PSA) Biomarker Breakdown Data by Application (2015-2026)

  • 5.1 Global Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020)
  • 5.2 Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Prostate Specific Antigen (PSA) Biomarker Market Size (2015-2020)
  • 6.2 Prostate Specific Antigen (PSA) Biomarker Key Players in North America (2019-2020)
  • 6.3 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020)
  • 6.4 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Prostate Specific Antigen (PSA) Biomarker Market Size (2015-2020)
  • 7.2 Prostate Specific Antigen (PSA) Biomarker Key Players in Europe (2019-2020)
  • 7.3 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020)
  • 7.4 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020)

8 China

  • 8.1 China Prostate Specific Antigen (PSA) Biomarker Market Size (2015-2020)
  • 8.2 Prostate Specific Antigen (PSA) Biomarker Key Players in China (2019-2020)
  • 8.3 China Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020)
  • 8.4 China Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Prostate Specific Antigen (PSA) Biomarker Market Size (2015-2020)
  • 9.2 Prostate Specific Antigen (PSA) Biomarker Key Players in Japan (2019-2020)
  • 9.3 Japan Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020)
  • 9.4 Japan Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Size (2015-2020)
  • 10.2 Prostate Specific Antigen (PSA) Biomarker Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020)

11 India

  • 11.1 India Prostate Specific Antigen (PSA) Biomarker Market Size (2015-2020)
  • 11.2 Prostate Specific Antigen (PSA) Biomarker Key Players in India (2019-2020)
  • 11.3 India Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020)
  • 11.4 India Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Prostate Specific Antigen (PSA) Biomarker Market Size (2015-2020)
  • 12.2 Prostate Specific Antigen (PSA) Biomarker Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020)
  • 12.4 Central & South America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Abbott
    • 13.1.1 Abbott Company Details
    • 13.1.2 Abbott Business Overview and Its Total Revenue
    • 13.1.3 Abbott Prostate Specific Antigen (PSA) Biomarker Introduction
    • 13.1.4 Abbott Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020))
    • 13.1.5 Abbott Recent Development
  • 13.2 Siemens Healthcare
    • 13.2.1 Siemens Healthcare Company Details
    • 13.2.2 Siemens Healthcare Business Overview and Its Total Revenue
    • 13.2.3 Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Introduction
    • 13.2.4 Siemens Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
    • 13.2.5 Siemens Healthcare Recent Development
  • 13.3 DiaSorin
    • 13.3.1 DiaSorin Company Details
    • 13.3.2 DiaSorin Business Overview and Its Total Revenue
    • 13.3.3 DiaSorin Prostate Specific Antigen (PSA) Biomarker Introduction
    • 13.3.4 DiaSorin Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
    • 13.3.5 DiaSorin Recent Development
  • 13.4 Roche
    • 13.4.1 Roche Company Details
    • 13.4.2 Roche Business Overview and Its Total Revenue
    • 13.4.3 Roche Prostate Specific Antigen (PSA) Biomarker Introduction
    • 13.4.4 Roche Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
    • 13.4.5 Roche Recent Development
  • 13.5 Tosoh Bioscience
    • 13.5.1 Tosoh Bioscience Company Details
    • 13.5.2 Tosoh Bioscience Business Overview and Its Total Revenue
    • 13.5.3 Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Introduction
    • 13.5.4 Tosoh Bioscience Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
    • 13.5.5 Tosoh Bioscience Recent Development
  • 13.6 Fujirebio
    • 13.6.1 Fujirebio Company Details
    • 13.6.2 Fujirebio Business Overview and Its Total Revenue
    • 13.6.3 Fujirebio Prostate Specific Antigen (PSA) Biomarker Introduction
    • 13.6.4 Fujirebio Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
    • 13.6.5 Fujirebio Recent Development
  • 13.7 BodiTech
    • 13.7.1 BodiTech Company Details
    • 13.7.2 BodiTech Business Overview and Its Total Revenue
    • 13.7.3 BodiTech Prostate Specific Antigen (PSA) Biomarker Introduction
    • 13.7.4 BodiTech Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
    • 13.7.5 BodiTech Recent Development
  • 13.8 GE Healthcare
    • 13.8.1 GE Healthcare Company Details
    • 13.8.2 GE Healthcare Business Overview and Its Total Revenue
    • 13.8.3 GE Healthcare Prostate Specific Antigen (PSA) Biomarker Introduction
    • 13.8.4 GE Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
    • 13.8.5 GE Healthcare Recent Development
  • 13.9 Endocare
    • 13.9.1 Endocare Company Details
    • 13.9.2 Endocare Business Overview and Its Total Revenue
    • 13.9.3 Endocare Prostate Specific Antigen (PSA) Biomarker Introduction
    • 13.9.4 Endocare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
    • 13.9.5 Endocare Recent Development
  • 13.10 Quest Diagnostics
    • 13.10.1 Quest Diagnostics Company Details
    • 13.10.2 Quest Diagnostics Business Overview and Its Total Revenue
    • 13.10.3 Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Introduction
    • 13.10.4 Quest Diagnostics Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
    • 13.10.5 Quest Diagnostics Recent Development
  • 13.11 Bio-Rad Laboratories
    • 10.11.1 Bio-Rad Laboratories Company Details
    • 10.11.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
    • 10.11.3 Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Introduction
    • 10.11.4 Bio-Rad Laboratories Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
    • 10.11.5 Bio-Rad Laboratories Recent Development
  • 13.12 QIAGEN
    • 10.12.1 QIAGEN Company Details
    • 10.12.2 QIAGEN Business Overview and Its Total Revenue
    • 10.12.3 QIAGEN Prostate Specific Antigen (PSA) Biomarker Introduction
    • 10.12.4 QIAGEN Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
    • 10.12.5 QIAGEN Recent Development
  • 13.13 Myriad RBM
    • 10.13.1 Myriad RBM Company Details
    • 10.13.2 Myriad RBM Business Overview and Its Total Revenue
    • 10.13.3 Myriad RBM Prostate Specific Antigen (PSA) Biomarker Introduction
    • 10.13.4 Myriad RBM Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
    • 10.13.5 Myriad RBM Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Summary:
    Get latest Market Research Reports on Prostate Specific Antigen (PSA) Biomarker. Industry analysis & Market Report on Prostate Specific Antigen (PSA) Biomarker is a syndicated market report, published as Global Prostate Specific Antigen (PSA) Biomarker Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Prostate Specific Antigen (PSA) Biomarker market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,088.80
    4,633.20
    6,177.60
    3,603.60
    5,405.40
    7,207.20
    590,031.00
    885,046.50
    1,180,062.00
    325,143.00
    487,714.50
    650,286.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report